Peter Gray is Director at Jazz Pharmaceuticals plc (JAZZ). They have made 9 open-market trades across 1 company since 2015, most recently 2023-08-14.
CIK 0001576096
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| JAZZ | 16,068 | $3.8M |
Shares reported on the most recent Form 4, priced at the 2023-08-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAZZ | SELL | 2023-08-14 | 2023-08-15 | $138.16 | $343K | +1.5% | -3.8% | -12.3% |
| JAZZ | SELL | 2022-08-18 | 2022-08-22 | $158.00 | $1.3M | -0.1% | -15.3% | -5.4% |
| JAZZ | SELL | 2022-08-08 | 2022-08-09 | $152.32 | $359K | -0.7% | -3.9% | -7.8% |
| JAZZ | SELL | 2021-08-06 | 2021-08-10 | $147.96 | $418K | -7.6% | -7.0% | -7.7% |
| JAZZ | SELL | 2019-08-09 | 2019-08-12 | $135.65 | $214K | -3.2% | -1.3% | -3.1% |
| JAZZ | SELL | 2018-08-10 | 2018-08-13 | $176.61 | $253K | -3.5% | -5.6% | -15.5% |
| JAZZ | SELL | 2017-08-11 | 2017-08-14 | $142.36 | $204K | +2.7% | +5.7% | -5.5% |
| JAZZ | SELL | 2015-08-10 | 2015-08-11 | $180.00 | $156K | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL | 2015-05-12 | 2015-05-14 | $173.86 | $122K | -10.8% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.